Sionna Therapeutics (SION) Change in Account Payables (2024 - 2026)
Sionna Therapeutics (SION) reported Change in Account Payables of $1.2 million for Q1 2026, down 65.98% on a YoY basis from $3.6 million in Q1 2025, and up 269.8% sequentially from -$712000.0 in Q4 2025.
Sionna Therapeutics (SION) Change in Account Payables (2024 - 2026) Analysis & Trends
Sionna Therapeutics (SION) has 3 years of Change in Account Payables data on file, last reported at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 65.98% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at -$2.8 million (down 217.48% YoY), and the FY2025 full-year result was -$417000.0, down 189.29% from the prior year.
- Change in Account Payables advanced to $1.2 million in Q1 2026, from -$712000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $3.6 million in Q1 2025 to a low of -$3.8 million in Q2 2025.
- A 3-year average of $139888.9 and a median of $567000.0 in 2025 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 132.22% in 2025, while the deepest fall reached 628.76% in 2025.
- Tracing SION's Change in Account Payables over 3 years: stood at $1.1 million in 2024, then slumped by 165.8% to -$712000.0 in 2025, then surged by 269.8% to $1.2 million in 2026.
- Business Quant data shows SION's Change in Account Payables at $1.2 million in Q1 2026, -$712000.0 in Q4 2025, and $567000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Sionna Therapeutics | 1.98 Bn | 1.98 Bn | - | 1.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.21 Mn |
| Mar 31, 2026 | 1.21 Mn |
| Dec 31, 2025 | -712,000.00 |
| Dec 31, 2025 | -712,000.00 |
| Sep 30, 2025 | 567,000.00 |
| Sep 30, 2025 | 567,000.00 |
| Jun 30, 2025 | -3.83 Mn |
| Jun 30, 2025 | -3.83 Mn |
| Mar 31, 2025 | 3.55 Mn |
| Mar 31, 2025 | 3.55 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | -1.76 Mn |
| Sep 30, 2024 | -1.76 Mn |
| Jun 30, 2024 | -525,000.00 |
| Jun 30, 2024 | -525,000.00 |
| Mar 31, 2024 | 1.67 Mn |
| Mar 31, 2024 | 1.67 Mn |